High level of serum cholesteryl ester transfer protein in active hepatitis C virus infection

World Journal of Hepatology

Volumn 8, Issue 5, 2016, Pages 291-300

  Satoh, Kenichi ^a   Nagano, Tomohisa ^a   Seki, Nobuyoshi ^a   Tomita, Yoichi ^a   Aida, Yuta ^a   Sugita, Tomonori ^a   Itagaki, Munenori ^a   Sutoh, Satoshi ^a   Abe, Hiroshi ^a   Aizawa, Yoshio ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Case control study; Cholesteryl ester transfer protein; Hepatitis C virus; High density lipoprotein triglyceride; Lipoprotein metabolism

Indexed keywords

EID: 84958749937     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v8.i5.291     Document Type: Article

References (38)

1. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-S46 [PMID:12407575 DOI:10.1002/hep.1840360706]
2. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36: S21-S29 [PMID:12407573 DOI:10.1002/hep.1840360704]
3. Casiraghi MA, De Paschale M, Romanò L, Biffi R, Assi A, Binelli G, Zanetti AR. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004; 39:90-96 [PMID:14752827 DOI:10.1002/hep.20030]
4. Bassendine MF, Sheridan DA, Bridge SH, Felmlee DJ, Neely RD. Lipids and HCV. Semin Immunopathol 2013; 35:87-100 [PMID:23111699 DOI:10.1007/s00281-012-0356-2]
5. Barth H, Liang TJ, Baumert TF. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 2006; 44:527-535 [PMID:16941688 DOI:10.1002/hep.21321]
6. Scholtes C, Ramière C, Rainteau D, Perrin-Cocon L, Wolf C, Humbert L, Carreras M, Guironnet-Paquet A, Zoulim F, Bartenschlager R, Lotteau V, André P, Diaz O. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients. Hepatology 2012; 56:39-48 [PMID:22290760 DOI:10.1002/hep.25628]
7. Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M, Ye J. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA 2007; 104:5848-5853 [PMID:17376867 DOI:10.1073/pnas.0700760104]
8. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chrétien Y, Koike K, Pessayre D, Chapman J, Barba G, Bréchot C. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002; 16:185-194 [PMID:11818366 DOI:10.1096/fj.01-0396com]
9. Yamaguchi A, Tazuma S, Nishioka T, Ohishi W, Hyogo H, Nomura S, Chayama K. Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci 2005; 50:1361-1371 [PMID:16047488 DOI:10.1007/s10620-005-2788-1]
10. Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P. Hepatitis C virusassociated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am J Gastroenterol 2003; 98:1150-1154 [PMID:12809841]
11. Nishimura M, Yamamoto H, Yoshida T, Seimiya M, Sawabe Y, Matsushita K, Umemura H, Sogawa K, Takizawa H, Yokosuka O, Nomura F. Decreases in the serum VLDL-TG/non-VLDL-TG ratio from early stages of chronic hepatitis C: alterations in TG-rich lipoprotein levels. PLoS One 2011; 6: e17309 [PMID:21364889 DOI:10.1371/journal.pone.0017309]
12. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 1998; 338:86-93 [PMID:9420339 DOI:10.1056/NEJM199801083380203]
13. deGoma EM, deGoma RL, Rader DJ. Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J Am Coll Cardiol 2008; 51:2199-2211 [PMID:18534265 DOI:10.1016/j.jacc.2008.03.016]
14. Nagano M, Yamashita S, Hirano K, Kujiraoka T, Ito M, Sagehashi Y, Hattori H, Nakajima N, Maruyama T, Sakai N, Egashira T, Matsuzawa Y. Point mutation (-69 G--> A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects. Arterioscler Thromb Vasc Biol 2001; 21:985-990 [PMID:11397708 DOI:10.1161/01. ATV.21.6.985]
15. Nagano M, Yamashita S, Hirano K, Ito M, Maruyama T, Ishihara M, Sagehashi Y, Oka T, Kujiraoka T, Hattori H, Nakajima N, Egashira T, Kondo M, Sakai N, Matsuzawa Y. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay. J Lipid Res 2002; 43:1011-1018 [PMID:12091484 DOI:10.1194/jlr.M200024-JLR200]
16. Usui S, Hara Y, Hosaki S, Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 2002; 43:805-814 [PMID:11971952]
17. Okazaki M, Usui S, Ishigami M, Sakai N, Nakamura T, Matsuzawa Y, Yamashita S. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography. Arterioscler Thromb Vasc Biol 2005; 25:578-584 [PMID:15637308 DOI:10.1161/01.ATV.0000155017.60171.88]
18. Yamashita S, Hui DY, Wetterau JR, Sprecher DL, Harmony JA, Sakai N, Matsuzawa Y, Tarui S. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism 1991; 40:756-763 [PMID:1870431 DOI:10.1016/0026-0495(91)90097-G]
19. Quinet EM, Agellon LB, Kroon PA, Marcel YL, Lee YC, Whitlock ME, Tall AR. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. J Clin Invest 1990; 85:357-363 [PMID:2298910 DOI:10.1172/JCI114446]
20. Jiang XC, Moulin P, Quinet E, Goldberg IJ, Yacoub LK, Agellon LB, Compton D, Schnitzer-Polokoff R, Tall AR. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem 1991; 266:4631-4639 [PMID:1999438]
21. Rashid S, Sniderman A, Melone M, Brown PE, Otvos JD, Mente A, Schulze K, McQueen MJ, Anand SS, Yusuf S. Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians. Eur J Prev Cardiol 2015; 22:468-477 [PMID:24659026 DOI:10.1177/2047487314528461]
22. Nakamura A, Niimura H, Kuwabara K, Takezaki T, Morita E, Wakai K, Hamajima N, Nishida Y, Turin TC, Suzuki S, Ohnaka K, Uemura H, Ozaki E, Hosono S, Mikami H, Kubo M, Tanaka H. Gene-gene combination effect and interactions among ABCA1, APOA1, SR-B1, and CETP polymorphisms for serum high-density lipoprotein-cholesterol in the Japanese population. PLoS One 2013; 8: e82046 [PMID:24376512 DOI:10.1371/journal.pone.0082046]
23. Suhy A, Hartmann K, Papp AC, Wang D, Sadee W. Regulation of cholesteryl ester transfer protein expression by upstream polymorphisms: reduced expression associated with rs247616. Pharmacogenet Genomics 2015; 25:394-401 [PMID:26061659 DOI:10.1097/FPC.0000000000000151]
24. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, Tall AR. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97:2917-2923 [PMID:8675707 DOI:10.1172/JCI118751]
25. Barter PJ, Kastelein JJ. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease. J Am Coll Cardiol 2006; 47:492-499 [PMID:16458126 DOI:10.1016/j.jacc.2005.09.042]
26. Inukai Y, Ito K, Hara K, Yamazaki A, Takebayashi K, Aso Y, Inukai T. Serum cholesteryl ester transfer protein concentrations are associated with serum levels of total cholesterol, beta-lipoprotein and apoproteins in patients with type 2 diabetes mellitus. Med Princ Pract 2007; 16:367-372 [PMID:17709925 DOI:10.1159/000104810]
27. Jones RJ, Owens D, Brennan C, Collins PB, Johnson AH, Tomkin GH. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II. Atherosclerosis 1996; 119:151-157 [PMID:8808492 DOI:10.1016/0021-9150(95)05639-4]
28. Maggi G, Bottelli R, Gola D, Perricone G, Posca M, Zavaglia C, Ideo G. Serum cholesterol and chronic hepatitis C. Ital J Gastroenterol 1996; 28:436-440 [PMID:9032585]
29. Nagano T, Seki N, Tomita Y, Sugita T, Aida Y, Itagaki M, Sutoh S, Abe H, Tsubota A, Aizawa Y. Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions. Int J Mol Sci 2015; 16:20576-20594 [PMID:26334270 DOI:10.3390/ijms160920576]
30. Clay MA, Newnham HH, Barter PJ. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler Thromb 1991; 11:415-422 [PMID:1900192 DOI:10.1161/01.ATV.11.2.415]
31. Shinohara Y, Imajo K, Yoneda M, Tomeno W, Ogawa Y, Fujita K, Kirikoshi H, Takahashi J, Funakoshi K, Ikeda M, Kato N, Nakajima A, Saito S. Hepatic triglyceride lipase plays an essential role in changing the lipid metabolism in genotype 1b hepatitis C virus replicon cells and hepatitis C patients. Hepatol Res 2013; 43:1190-1198 [PMID:23607715 DOI:10.1111/hepr.12072]
32. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC. High-density lipoprotein function recent advances. J Am Coll Cardiol 2005; 46:1792-1798 [PMID:16286161]
33. Olubamwo OO, Onyeka IN, Miettola J, Kauhanen J, Tuomainen TP. Hepatitis C as a risk factor for carotid atherosclerosis-a systematic review. Clin Physiol Funct Imaging 2015; Epub ahead of print [PMID:25620553 DOI:10.1111/cpf.12229]
34. Felmlee DJ, Sheridan DA, Bridge SH, Nielsen SU, Milne RW, Packard CJ, Caslake MJ, McLauchlan J, Toms GL, Neely RD, Bassendine MF. Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles. Gastroenterology 2010; 139:1774-1783, 1783.e1-6 [PMID:20682323 DOI:10.1053/j.gastro.2010.07.047]
35. Bridge SH, Sheridan DA, Felmlee DJ, Nielsen SU, Thomas HC, Taylor-Robinson SD, Neely RD, Toms GL, Bassendine MF. Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection. Gut 2011; 60:680-687 [PMID:20940286 DOI:10.1136/gut.2010.222133]
36. Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 2002; 161:1-16 [PMID:11882312]
37. Zhang H, Reilly MP. Anti-inflammatory effects of high-density lipoprotein through activating transcription factor 3: benefit beyond cholesterol transport-dependent processes. Arterioscler Thromb Vasc Biol 2014; 34: e11-e12 [PMID:24743432 DOI:10.1161/ATVBAHA.114.303553]
38. Fogelman AM. When good cholesterol goes bad. Nat Med 2004; 10:902-903 [PMID:15340411]